Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1α promoter methylation in healthy subjects
FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs mitochondrial function and alters PGC-1α promoter methylation. In this uncontrolled, change from baseline study design, insulin sensitivity...
Saved in:
| Published in | PloS one Vol. 12; no. 12; p. e0188208 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
20.12.2017
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1932-6203 1932-6203 |
| DOI | 10.1371/journal.pone.0188208 |
Cover
Loading…
| Abstract | FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs mitochondrial function and alters PGC-1α promoter methylation.
In this uncontrolled, change from baseline study design, insulin sensitivity and glucose-stimulated insulin secretion were measured in 9 normal glucose tolerant subjects before and after 3 day lipid infusion to elevate plasma FFA concentration. Vastus lateralis muscle biopsies were obtained and mitochondrial function, PGC-1α expression, and PGC-1α promoter methylation were quantitated.
Increased plasma FFA (440±93 μmol/Lto 997±242 μM, p<0.001) decreased insulin-stimulated total glucose disposal (TGD) by 25% (p = 0.008), impaired suppression of endogenous glucose production (p = 0.01), and reduced mitochondrial ATP synthesis with complex 1 (34%, p<0.05) and complex 2 (30%, p<0.05) substrates. Lipid infusion had no effect on muscle PGC-1α RNA expression, total methylation or non-CpG methylation, but methylation of the alternative PGC-1α promoter decreased (1.30±0.30 to 0.84±0.15% methylated residues/patient•strand, p = 0.055). Within PGC-1α promoter there was demethylation of CpT residues (0.72±0.16 vs. 0.28±0.10 methylated residues/patient•strand) (p = 0.002), which was inversely correlated with PGC-1α mRNA expression (r = -0.94, p<0.0001) and ATP synthesis with complex 1 (r = -0.80, p<0.01) and complex 2 (r = -0.69, p<0.05) substrates. Lipid infusion increased DNMT-3B (methyltransferase associated with PGC-1α promoter non-CpG methylation) mRNA expression (0.87 ± 0.09 to 1.62 ± 0.22 arbitrary units, p = 0.005), which correlated inversely with CpT demethylation (r = 0.67, p<0.05).
Physiologic plasma FFA elevation in NGT individuals has opposing effects on PGC-1α non-CpG residue methylation (CpT demethylation and increased DNMT-3B expression), which is correlated with changes in PGC-1α expression and skeletal muscle mitochondrial function. |
|---|---|
| AbstractList | Aims FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs mitochondrial function and alters PGC-1α promoter methylation. Methods In this uncontrolled, change from baseline study design, insulin sensitivity and glucose-stimulated insulin secretion were measured in 9 normal glucose tolerant subjects before and after 3 day lipid infusion to elevate plasma FFA concentration. Vastus lateralis muscle biopsies were obtained and mitochondrial function, PGC-1α expression, and PGC-1α promoter methylation were quantitated. Results Increased plasma FFA (440±93 μmol/Lto 997±242 μM, p<0.001) decreased insulin-stimulated total glucose disposal (TGD) by 25% (p = 0.008), impaired suppression of endogenous glucose production (p = 0.01), and reduced mitochondrial ATP synthesis with complex 1 (34%, p<0.05) and complex 2 (30%, p<0.05) substrates. Lipid infusion had no effect on muscle PGC-1α RNA expression, total methylation or non-CpG methylation, but methylation of the alternative PGC-1α promoter decreased (1.30±0.30 to 0.84±0.15% methylated residues/patient•strand, p = 0.055). Within PGC-1α promoter there was demethylation of CpT residues (0.72±0.16 vs. 0.28±0.10 methylated residues/patient•strand) (p = 0.002), which was inversely correlated with PGC-1α mRNA expression (r = -0.94, p<0.0001) and ATP synthesis with complex 1 (r = -0.80, p<0.01) and complex 2 (r = -0.69, p<0.05) substrates. Lipid infusion increased DNMT-3B (methyltransferase associated with PGC-1α promoter non-CpG methylation) mRNA expression (0.87 ± 0.09 to 1.62 ± 0.22 arbitrary units, p = 0.005), which correlated inversely with CpT demethylation (r = 0.67, p<0.05). Conclusion/Interpretation Physiologic plasma FFA elevation in NGT individuals has opposing effects on PGC-1α non-CpG residue methylation (CpT demethylation and increased DNMT-3B expression), which is correlated with changes in PGC-1α expression and skeletal muscle mitochondrial function. Aims FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs mitochondrial function and alters PGC-1α promoter methylation. Methods In this uncontrolled, change from baseline study design, insulin sensitivity and glucose-stimulated insulin secretion were measured in 9 normal glucose tolerant subjects before and after 3 day lipid infusion to elevate plasma FFA concentration. Vastus lateralis muscle biopsies were obtained and mitochondrial function, PGC-1α expression, and PGC-1α promoter methylation were quantitated. Results Increased plasma FFA (440±93 μmol/Lto 997±242 μM, p<0.001) decreased insulin-stimulated total glucose disposal (TGD) by 25% (p = 0.008), impaired suppression of endogenous glucose production (p = 0.01), and reduced mitochondrial ATP synthesis with complex 1 (34%, p<0.05) and complex 2 (30%, p<0.05) substrates. Lipid infusion had no effect on muscle PGC-1α RNA expression, total methylation or non-CpG methylation, but methylation of the alternative PGC-1α promoter decreased (1.30±0.30 to 0.84±0.15% methylated residues/patient•strand, p = 0.055). Within PGC-1α promoter there was demethylation of CpT residues (0.72±0.16 vs. 0.28±0.10 methylated residues/patient•strand) (p = 0.002), which was inversely correlated with PGC-1α mRNA expression (r = -0.94, p<0.0001) and ATP synthesis with complex 1 (r = -0.80, p<0.01) and complex 2 (r = -0.69, p<0.05) substrates. Lipid infusion increased DNMT-3B (methyltransferase associated with PGC-1α promoter non-CpG methylation) mRNA expression (0.87 ± 0.09 to 1.62 ± 0.22 arbitrary units, p = 0.005), which correlated inversely with CpT demethylation (r = 0.67, p<0.05). Conclusion/Interpretation Physiologic plasma FFA elevation in NGT individuals has opposing effects on PGC-1α non-CpG residue methylation (CpT demethylation and increased DNMT-3B expression), which is correlated with changes in PGC-1α expression and skeletal muscle mitochondrial function. FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs mitochondrial function and alters PGC-1α promoter methylation. In this uncontrolled, change from baseline study design, insulin sensitivity and glucose-stimulated insulin secretion were measured in 9 normal glucose tolerant subjects before and after 3 day lipid infusion to elevate plasma FFA concentration. Vastus lateralis muscle biopsies were obtained and mitochondrial function, PGC-1α expression, and PGC-1α promoter methylation were quantitated. Increased plasma FFA (440±93 μmol/Lto 997±242 μM, p<0.001) decreased insulin-stimulated total glucose disposal (TGD) by 25% (p = 0.008), impaired suppression of endogenous glucose production (p = 0.01), and reduced mitochondrial ATP synthesis with complex 1 (34%, p<0.05) and complex 2 (30%, p<0.05) substrates. Lipid infusion had no effect on muscle PGC-1α RNA expression, total methylation or non-CpG methylation, but methylation of the alternative PGC-1α promoter decreased (1.30±0.30 to 0.84±0.15% methylated residues/patient•strand, p = 0.055). Within PGC-1α promoter there was demethylation of CpT residues (0.72±0.16 vs. 0.28±0.10 methylated residues/patient•strand) (p = 0.002), which was inversely correlated with PGC-1α mRNA expression (r = -0.94, p<0.0001) and ATP synthesis with complex 1 (r = -0.80, p<0.01) and complex 2 (r = -0.69, p<0.05) substrates. Lipid infusion increased DNMT-3B (methyltransferase associated with PGC-1α promoter non-CpG methylation) mRNA expression (0.87 ± 0.09 to 1.62 ± 0.22 arbitrary units, p = 0.005), which correlated inversely with CpT demethylation (r = 0.67, p<0.05). Physiologic plasma FFA elevation in NGT individuals has opposing effects on PGC-1α non-CpG residue methylation (CpT demethylation and increased DNMT-3B expression), which is correlated with changes in PGC-1α expression and skeletal muscle mitochondrial function. FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs mitochondrial function and alters PGC-1α promoter methylation.AIMSFFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs mitochondrial function and alters PGC-1α promoter methylation.In this uncontrolled, change from baseline study design, insulin sensitivity and glucose-stimulated insulin secretion were measured in 9 normal glucose tolerant subjects before and after 3 day lipid infusion to elevate plasma FFA concentration. Vastus lateralis muscle biopsies were obtained and mitochondrial function, PGC-1α expression, and PGC-1α promoter methylation were quantitated.METHODSIn this uncontrolled, change from baseline study design, insulin sensitivity and glucose-stimulated insulin secretion were measured in 9 normal glucose tolerant subjects before and after 3 day lipid infusion to elevate plasma FFA concentration. Vastus lateralis muscle biopsies were obtained and mitochondrial function, PGC-1α expression, and PGC-1α promoter methylation were quantitated.Increased plasma FFA (440±93 μmol/Lto 997±242 μM, p<0.001) decreased insulin-stimulated total glucose disposal (TGD) by 25% (p = 0.008), impaired suppression of endogenous glucose production (p = 0.01), and reduced mitochondrial ATP synthesis with complex 1 (34%, p<0.05) and complex 2 (30%, p<0.05) substrates. Lipid infusion had no effect on muscle PGC-1α RNA expression, total methylation or non-CpG methylation, but methylation of the alternative PGC-1α promoter decreased (1.30±0.30 to 0.84±0.15% methylated residues/patient•strand, p = 0.055). Within PGC-1α promoter there was demethylation of CpT residues (0.72±0.16 vs. 0.28±0.10 methylated residues/patient•strand) (p = 0.002), which was inversely correlated with PGC-1α mRNA expression (r = -0.94, p<0.0001) and ATP synthesis with complex 1 (r = -0.80, p<0.01) and complex 2 (r = -0.69, p<0.05) substrates. Lipid infusion increased DNMT-3B (methyltransferase associated with PGC-1α promoter non-CpG methylation) mRNA expression (0.87 ± 0.09 to 1.62 ± 0.22 arbitrary units, p = 0.005), which correlated inversely with CpT demethylation (r = 0.67, p<0.05).RESULTSIncreased plasma FFA (440±93 μmol/Lto 997±242 μM, p<0.001) decreased insulin-stimulated total glucose disposal (TGD) by 25% (p = 0.008), impaired suppression of endogenous glucose production (p = 0.01), and reduced mitochondrial ATP synthesis with complex 1 (34%, p<0.05) and complex 2 (30%, p<0.05) substrates. Lipid infusion had no effect on muscle PGC-1α RNA expression, total methylation or non-CpG methylation, but methylation of the alternative PGC-1α promoter decreased (1.30±0.30 to 0.84±0.15% methylated residues/patient•strand, p = 0.055). Within PGC-1α promoter there was demethylation of CpT residues (0.72±0.16 vs. 0.28±0.10 methylated residues/patient•strand) (p = 0.002), which was inversely correlated with PGC-1α mRNA expression (r = -0.94, p<0.0001) and ATP synthesis with complex 1 (r = -0.80, p<0.01) and complex 2 (r = -0.69, p<0.05) substrates. Lipid infusion increased DNMT-3B (methyltransferase associated with PGC-1α promoter non-CpG methylation) mRNA expression (0.87 ± 0.09 to 1.62 ± 0.22 arbitrary units, p = 0.005), which correlated inversely with CpT demethylation (r = 0.67, p<0.05).Physiologic plasma FFA elevation in NGT individuals has opposing effects on PGC-1α non-CpG residue methylation (CpT demethylation and increased DNMT-3B expression), which is correlated with changes in PGC-1α expression and skeletal muscle mitochondrial function.CONCLUSION/INTERPRETATIONPhysiologic plasma FFA elevation in NGT individuals has opposing effects on PGC-1α non-CpG residue methylation (CpT demethylation and increased DNMT-3B expression), which is correlated with changes in PGC-1α expression and skeletal muscle mitochondrial function. |
| Author | DeFronzo, Ralph A. Abdul-Ghani, Muhammad Fourcaudot, Marcel Galindo, Cynthia Norton, Luke Eldor, Roy |
| AuthorAffiliation | 1 Diabetes Unit, Institute for Metabolism, Endocrinology and Hypertension, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 2 Division of Diabetes, University of Texas Health Science Center, San Antonio, Texas, United States of America Virgen Macarena University Hospital, School of Medicine, University of Seville, SPAIN |
| AuthorAffiliation_xml | – name: Virgen Macarena University Hospital, School of Medicine, University of Seville, SPAIN – name: 1 Diabetes Unit, Institute for Metabolism, Endocrinology and Hypertension, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel – name: 2 Division of Diabetes, University of Texas Health Science Center, San Antonio, Texas, United States of America |
| Author_xml | – sequence: 1 givenname: Roy orcidid: 0000-0002-1151-1370 surname: Eldor fullname: Eldor, Roy – sequence: 2 givenname: Luke surname: Norton fullname: Norton, Luke – sequence: 3 givenname: Marcel surname: Fourcaudot fullname: Fourcaudot, Marcel – sequence: 4 givenname: Cynthia surname: Galindo fullname: Galindo, Cynthia – sequence: 5 givenname: Ralph A. surname: DeFronzo fullname: DeFronzo, Ralph A. – sequence: 6 givenname: Muhammad surname: Abdul-Ghani fullname: Abdul-Ghani, Muhammad |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29261667$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Us2O0zAYjNAi9gfeAIElLhxosfPjJByQUAVLpZXgAGfri_2ldXHsYDuL-lg8BTeeCXfbot0V4mRrPDMef57z7MQ6i1n2lNE5K2r2euMmb8HMxwTPKWuanDYPsjPWFvmM57Q4ubU_zc5D2FBaFQ3nj7LTvM0547w-y34trfQIARUxetSKwDVoA502Om5J7zyJa49IFGwD8agmiYH8WDuDpHNqS1Zmki4gmcYI3_AV0cMI2gcyTEEmzqCjk2tnlddgSD9ZGbWzBKwi2uqoISY7N44uaLsi2PcoYwIs-Xy5mLHfP8no3eAiejJgXG8N3Mi1JWsEkwASpm6z0zzOHvZgAj45rBfZ1w_vvyw-zq4-XS4X765mssp5nHVU1oBtBaxsoevaXrK-qfO8lgXFsuSd6lssK16ommMllaK0Bso5VNhSzKG4yJ7vfUfjgjj8QRCsrdu6TgMuE2O5ZygHGzF6PYDfCgda3ADOrwT4qNN0BFNFx3OssZRViSVtK5Y3bdt1fUNVVTXJ6-3htqkbUEm00YO5Y3r3xOq1WLlrUdVFClQkg5cHA---TxiiGHSQaAxYdNM-d0UbVuyoL-5R__26Z7cT_Y1ybFQivNkTpHcheOyF1PHm21JAbQSjYlffo7nY1Vcc6pvE5T3x0f-_sj_FQ_4h |
| CitedBy_id | crossref_primary_10_18632_aging_103219 crossref_primary_10_1016_j_dsx_2021_102280 crossref_primary_10_3390_ijms21186948 crossref_primary_10_1186_s12944_018_0872_8 crossref_primary_10_1097_MCO_0000000000000480 crossref_primary_10_1134_S1022795424701060 crossref_primary_10_1186_s12944_024_02079_z |
| Cites_doi | 10.1172/JCI115399 10.1093/abbs/gms075 10.1016/j.cmet.2012.01.001 10.2337/db13-1130 10.2337/diabetes.52.10.2461 10.1056/NEJMoa031314 10.1016/j.bbrc.2009.02.077 10.1371/journal.pone.0129647 10.1152/ajpheart.00081.2008 10.1210/jc.2009-1387 10.3945/ajcn.110.001917 10.1016/j.cmet.2005.03.002 10.1152/ajplegacy.1956.187.1.15 10.1093/dnares/dst029 10.2337/diabetes.51.10.3043 10.2337/diab.44.8.863 10.1038/nn.3607 10.1172/JCI29103 10.1152/ajpendo.00541.2003 10.1152/ajpendo.90287.2008 10.1210/jc.2003-030723 10.1210/jc.2009-2413 10.2337/db06-0840 10.1016/j.drudis.2011.05.004 10.1172/JCI7535 10.1126/science.1210597 10.1016/S0092-8674(00)81656-6 10.2337/diabetes.51.10.2944 10.1210/jc.2004-0224 10.1007/s00125-009-1264-4 10.1016/j.cmet.2009.07.011 10.1210/en.2008-0466 10.1074/jbc.M408985200 10.2337/db09-9028 10.1172/JCI111133 10.2337/diabetes.48.2.358 10.1016/S0092-8674(00)80611-X 10.1113/jphysiol.2012.247510 10.1073/pnas.0810339105 |
| ContentType | Journal Article |
| Copyright | 2017 Eldor et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2017 Eldor et al 2017 Eldor et al |
| Copyright_xml | – notice: 2017 Eldor et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2017 Eldor et al 2017 Eldor et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0188208 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Agricultural Science Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | Lipid availability and PGC-1α promoter methylation |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1979770054 oai_doaj_org_article_1d3b62e7e4c54e409512899bbf80d558 PMC5737973 29261667 10_1371_journal_pone_0188208 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: R01 DK024092 – fundername: NIDDK NIH HHS grantid: R56 DK024092 – fundername: NIDDK NIH HHS grantid: R01 DK097554 – fundername: ; grantid: NIH-DK 24092-42 – fundername: ; grantid: R01 DK097554-01 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM BBORY CGR CUY CVF ECM EIF IPNFZ NPM RIG 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI RC3 7X8 5PM PUEGO AAPBV ABPTK N95 |
| ID | FETCH-LOGICAL-c526t-b0c7ae95a149abb9fc1f87227c30e446bdf9e4563d76e5cdd007a066a5e90e2a3 |
| IEDL.DBID | DOA |
| ISSN | 1932-6203 |
| IngestDate | Sun Jun 04 06:37:02 EDT 2023 Wed Aug 27 01:29:28 EDT 2025 Thu Aug 21 17:41:01 EDT 2025 Fri Jul 11 00:08:52 EDT 2025 Fri Jul 25 11:40:22 EDT 2025 Thu Apr 03 07:00:32 EDT 2025 Tue Jul 01 03:40:13 EDT 2025 Thu Apr 24 22:54:16 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c526t-b0c7ae95a149abb9fc1f87227c30e446bdf9e4563d76e5cdd007a066a5e90e2a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: RAD has the following competing interests - Advisory Board: Astra Zeneca, Novo Nordisk, Janssen, Intarcia, Boehringer-Ingelheim; Research Support: Bristol Myers Squibb, Boehringer-Ingelheim, Takeda, Astra Zeneca; Speaker’s Bureau: Novo-Nordisk, Astra Zeneca. Other authors have no conflict of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no restrictions in sharing data and/or materials. |
| ORCID | 0000-0002-1151-1370 |
| OpenAccessLink | https://doaj.org/article/1d3b62e7e4c54e409512899bbf80d558 |
| PMID | 29261667 |
| PQID | 1979770054 |
| PQPubID | 1436336 |
| ParticipantIDs | plos_journals_1979770054 doaj_primary_oai_doaj_org_article_1d3b62e7e4c54e409512899bbf80d558 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5737973 proquest_miscellaneous_1979508133 proquest_journals_1979770054 pubmed_primary_29261667 crossref_citationtrail_10_1371_journal_pone_0188208 crossref_primary_10_1371_journal_pone_0188208 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-12-20 |
| PublicationDateYYYYMMDD | 2017-12-20 |
| PublicationDate_xml | – month: 12 year: 2017 text: 2017-12-20 day: 20 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2017 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | S Miura (ref35) 2008; 149 C Brons (ref21) 2010; 95 R Steele (ref26) 1956; 187 K Cusi (ref24) 2000; 105 DK Richardson (ref19) 2005; 280 MA Abdul-Ghani (ref25) 2008; 295 M Roden (ref7) 1999; 48 PJ Fernandez-Marcos (ref17) 2011; 93 Z Wu (ref18) 1999; 98 JU Guo (ref40) 2014; 17 D Bellizzi (ref39) 2013; 20 G Daniele (ref13) 2014; 63 Z Arany (ref27) 2005; 1 CS Choi (ref29) 2008; 105 RA Defronzo (ref1) 2009; 58 RH Unger (ref2) 1995; 44 AO Chavez (ref22) 2010; 95 TL Lochmann (ref36) 2015; 10 RA DeFronzo (ref23) 1979; 237 M Bajaj (ref32) 2007; 56 S Kashyap (ref11) 2003; 52 R Barres (ref20) 2009; 10 KF Petersen (ref14) 2004; 350 N Carey (ref38) 2011; 16 G Boden (ref8) 1991; 88 H Bays (ref4) 2004; 89 M Prentki (ref3) 2006; 116 R Barres (ref33) 2012; 15 E Ferrannini (ref6) 1983; 72 M Bajaj (ref12) 2004; 89 S Ito (ref37) 2011; 333 M Bajaj (ref9) 2002; 51 H Liang (ref31) 2013; 591 Y Jiang (ref41) 2012; 44 SR Kashyap (ref10) 2004; 287 M Okano (ref30) 1999; 99 RC Bonadonna (ref5) 1989; 257 DE Kelley (ref16) 2002; 51 JJ Lehman (ref28) 2008; 295 T Yoshioka (ref34) 2009; 381 MA Abdul-Ghani (ref15) 2009; 52 |
| References_xml | – volume: 88 start-page: 960 issue: 3 year: 1991 ident: ref8 article-title: Effects of fat on insulin-stimulated carbohydrate metabolism in normal men publication-title: J Clin Invest doi: 10.1172/JCI115399 – volume: 44 start-page: 866 issue: 10 year: 2012 ident: ref41 article-title: The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE-/- mice publication-title: Acta Biochim Biophys Sin (Shanghai) doi: 10.1093/abbs/gms075 – volume: 15 start-page: 405 issue: 3 year: 2012 ident: ref33 article-title: Acute exercise remodels promoter methylation in human skeletal muscle publication-title: Cell Metab doi: 10.1016/j.cmet.2012.01.001 – volume: 63 start-page: 2812 issue: 8 year: 2014 ident: ref13 article-title: Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals publication-title: Diabetes doi: 10.2337/db13-1130 – volume: 52 start-page: 2461 issue: 10 year: 2003 ident: ref11 article-title: A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes publication-title: Diabetes doi: 10.2337/diabetes.52.10.2461 – volume: 350 start-page: 664 issue: 7 year: 2004 ident: ref14 article-title: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa031314 – volume: 381 start-page: 537 issue: 4 year: 2009 ident: ref34 article-title: Identification and characterization of an alternative promoter of the human PGC-1alpha gene publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2009.02.077 – volume: 10 start-page: e0129647 issue: 6 year: 2015 ident: ref36 article-title: Epigenetic Modifications of the PGC-1alpha Promoter during Exercise Induced Expression in Mice publication-title: PLoS One doi: 10.1371/journal.pone.0129647 – volume: 295 start-page: H185 issue: 1 year: 2008 ident: ref28 article-title: The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00081.2008 – volume: 95 start-page: 422 issue: 1 year: 2010 ident: ref22 article-title: Effect of short-term free Fatty acids elevation on mitochondrial function in skeletal muscle of healthy individuals publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2009-1387 – volume: 93 start-page: 884S issue: 4 year: 2011 ident: ref17 article-title: Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis publication-title: Am J Clin Nutr doi: 10.3945/ajcn.110.001917 – volume: 1 start-page: 259 issue: 4 year: 2005 ident: ref27 article-title: Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle publication-title: Cell Metab doi: 10.1016/j.cmet.2005.03.002 – volume: 257 start-page: E49 issue: 1 Pt 1 year: 1989 ident: ref5 article-title: Time dependence of the interaction between lipid and glucose in humans publication-title: Am J Physiol – volume: 187 start-page: 15 issue: 1 year: 1956 ident: ref26 article-title: Measurement of size and turnover rate of body glucose pool by the isotope dilution method publication-title: Am J Physiol doi: 10.1152/ajplegacy.1956.187.1.15 – volume: 20 start-page: 537 issue: 6 year: 2013 ident: ref39 article-title: The control region of mitochondrial DNA shows an unusual CpG and non-CpG methylation pattern publication-title: DNA Res doi: 10.1093/dnares/dst029 – volume: 51 start-page: 3043 issue: 10 year: 2002 ident: ref9 article-title: Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes publication-title: Diabetes doi: 10.2337/diabetes.51.10.3043 – volume: 44 start-page: 863 issue: 8 year: 1995 ident: ref2 article-title: Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications publication-title: Diabetes doi: 10.2337/diab.44.8.863 – volume: 17 start-page: 215 issue: 2 year: 2014 ident: ref40 article-title: Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain publication-title: Nat Neurosci doi: 10.1038/nn.3607 – volume: 237 start-page: E214 issue: 3 year: 1979 ident: ref23 article-title: Glucose clamp technique: a method for quantifying insulin secretion and resistance publication-title: Am J Physiol – volume: 116 start-page: 1802 issue: 7 year: 2006 ident: ref3 article-title: Islet beta cell failure in type 2 diabetes publication-title: J Clin Invest doi: 10.1172/JCI29103 – volume: 287 start-page: E537 issue: 3 year: 2004 ident: ref10 article-title: Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00541.2003 – volume: 295 start-page: E678 issue: 3 year: 2008 ident: ref25 article-title: Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.90287.2008 – volume: 89 start-page: 463 issue: 2 year: 2004 ident: ref4 article-title: Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-030723 – volume: 95 start-page: 3048 issue: 6 year: 2010 ident: ref21 article-title: Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2009-2413 – volume: 56 start-page: 743 issue: 3 year: 2007 ident: ref32 article-title: Paradoxical changes in muscle gene expression in insulin-resistant subjects after sustained reduction in plasma free fatty acid concentration publication-title: Diabetes doi: 10.2337/db06-0840 – volume: 16 start-page: 683 issue: 15–16 year: 2011 ident: ref38 article-title: DNA demethylases: a new epigenetic frontier in drug discovery publication-title: Drug Discov Today doi: 10.1016/j.drudis.2011.05.004 – volume: 105 start-page: 311 issue: 3 year: 2000 ident: ref24 article-title: Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle publication-title: J Clin Invest doi: 10.1172/JCI7535 – volume: 333 start-page: 1300 issue: 6047 year: 2011 ident: ref37 article-title: Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine publication-title: Science doi: 10.1126/science.1210597 – volume: 99 start-page: 247 issue: 3 year: 1999 ident: ref30 article-title: DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development publication-title: Cell doi: 10.1016/S0092-8674(00)81656-6 – volume: 51 start-page: 2944 issue: 10 year: 2002 ident: ref16 article-title: Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes publication-title: Diabetes doi: 10.2337/diabetes.51.10.2944 – volume: 89 start-page: 4649 issue: 9 year: 2004 ident: ref12 article-title: Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-0224 – volume: 52 start-page: 574 issue: 4 year: 2009 ident: ref15 article-title: Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants publication-title: Diabetologia doi: 10.1007/s00125-009-1264-4 – volume: 10 start-page: 189 issue: 3 year: 2009 ident: ref20 article-title: Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density publication-title: Cell Metab doi: 10.1016/j.cmet.2009.07.011 – volume: 149 start-page: 4527 issue: 9 year: 2008 ident: ref35 article-title: Isoform-specific increases in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to beta2-adrenergic receptor activation and exercise publication-title: Endocrinology doi: 10.1210/en.2008-0466 – volume: 280 start-page: 10290 issue: 11 year: 2005 ident: ref19 article-title: Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle publication-title: J Biol Chem doi: 10.1074/jbc.M408985200 – volume: 58 start-page: 773 issue: 4 year: 2009 ident: ref1 article-title: Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus publication-title: Diabetes doi: 10.2337/db09-9028 – volume: 72 start-page: 1737 issue: 5 year: 1983 ident: ref6 article-title: Effect of fatty acids on glucose production and utilization in man publication-title: J Clin Invest doi: 10.1172/JCI111133 – volume: 48 start-page: 358 issue: 2 year: 1999 ident: ref7 article-title: Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans publication-title: Diabetes doi: 10.2337/diabetes.48.2.358 – volume: 98 start-page: 115 issue: 1 year: 1999 ident: ref18 article-title: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 publication-title: Cell doi: 10.1016/S0092-8674(00)80611-X – volume: 591 start-page: 2897 issue: 11 year: 2013 ident: ref31 article-title: Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects publication-title: J Physiol doi: 10.1113/jphysiol.2012.247510 – volume: 105 start-page: 19926 issue: 50 year: 2008 ident: ref29 article-title: Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0810339105 |
| SSID | ssj0053866 |
| Score | 2.291351 |
| Snippet | FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs... Aims FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA... AIMS:FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA... Aims FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA... |
| SourceID | plos doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0188208 |
| SubjectTerms | Adenosine Triphosphate - biosynthesis Adult ATP Baseline studies Beta cells Biology and life sciences Catheters Correlation CpG islands Demethylation Deoxyribonucleic acid Diabetes DNA DNA Methylation Endocrinology Epigenetics Fatty acids Fatty Acids, Nonesterified - blood Female Gene expression Glucose Glucose - metabolism Healthy Volunteers Humans Insulin Insulin - metabolism Insulin Resistance Insulin Secretion Lipid Metabolism Lipids Male Medicine and Health Sciences Metabolism Metabolites Methylation Methyltransferase Mitochondria Mitochondria, Muscle - metabolism Mitochondria, Muscle - physiology Mitochondrial DNA Muscles Musculoskeletal system Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha - genetics Physical Sciences Plasma Residues Ribonucleic acid RNA Rodents Secretion Skeletal muscle Studies Substrates Synthesis Veins & arteries Young Adult |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Nb9QwELWgXLggyleXFjRIHEAi7caO480JQUWpOCAOVNpbZMeTErFNwma3aH8Wv4Ibv4mZxLt0UQXXtb1JNDP2G_v5jRDP0xQxy7SKyolUlKDYMnK0ElCWgonBMmN9FmZbfExPz5IPUz0NG25doFWu58R-ovZNwXvkR3FmCKowwnjdfou4ahSfroYSGjfFLZYuY0qXmW4SLorlNA3X5ZSJj4J1DtumxsNxTNiSi0peWY561X5WOZ013XWI82_i5JWV6OSuuBMgJLwZbL4rbmB9T-yGIO3gRVCSfnlf_KToZ9I5ephVbeXBXtpqNihzr4DgKizIlAjerjqYs4grjf_OFXPBNX4Fgc8Oy3Zhv-Ir4CuV1byDi2VHT4YLmg1o9qw9OzHwCslWBlt7qJiTxDAWmpZ5YfU5BOYIUI9P74-j-NcPaHsuIM6B61ivBlYeDYXhcuYKuqXjbaLugTg7eff5-DQKlRuiQst0EblxYSxm2lL-ZZ3LyiIuJ0ZKU6gxUgLqfJkhQTflTYq68J6QiiXwYzVmY5RWPRQ7NVlpT4DUkjo4XcQEVK2l7DDBwk9SQrKxUVkyEmptwLwIsuZcXWOW92d1htKbwSw5mz0PZh-JaDOqHWQ9_tP_LfvGpi-Lcvc_NPPzPMR4HnvlUokGk0InmDB45XTWuXIy9lrTn-yxZ60f0OV_fHokDtbedn3zs00zhT-f6dgam-XQhzB2rNRIPBqcc_OSMqP0OE3NSJgtt936iu2WuvrSS4xro-jZ6vG_X2tf3JaMcmJJk-2B2FnMl_iEMNrCPe0D8TcGF0RU priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NjtMwELZWy4ULYvnbwoIGiQNIZNXYsd0cEIIVywoJxIFKe4vs2FkiuklIWiCPxVNw45mYSdyKoiIuXGtP3WRmPN_U428Ye6SU92kqRVTMuMAExRSRxUiAWYpPtC9S4mehaot36myevDmX53ts3bM1vMBuZ2pH_aTm7eL42-f-OTr8s6Frg47XQsdNXfnjaYyYkW7_XsHYpMlV3yabcwX0bqXCBbq_SW4FqIHHn3hPF3W3C4P-WUr5W2w6vc6uBVAJL0YrOGB7vrrBDoLbdvA4cEs_ucl-4H5AZejewaJsSgfmiykXI1d3DwhgYYnK9eBM30FLtK4o_5V66IKtXQ-hwh1WzdJ88k-BLlmWbQeXqw5XhkvcH_CVVo7MGihmkt7BVA5KqlIiYAt1Q5Vi1QWEWhLAGe9fn0Txz-_QDNWBvgXqbN2PdXooCuN1zR66laU_jrpbbH766sPJWRR6OUS55GoZ2WmujU-lwYzMWJsWeVzMNOc6F1OPKal1ReoRzAmnlZe5c4hdDMIhI3069dyI22y_Qi0dMuCS4wQr8xihqzGYLyY-dzOF2DbWIk0mTKwVmOWB6Jz6bSyy4fROY8IzqiUjtWdB7RMWbaSakejjH_Nfkm1s5hJN9_BB3V5kweuz2AmruNc-yWXiE4KzlOBaW8ymTkr8kkOyrPUCXRanGgE54egJO1pb2-7hh5th3BDolMdUvl6NcxB1x0JM2J3RODc_kqeYMCulJ0xvme3WU2yPVOXHgXRcaoFri7v_47Hvsauc0FHMcZM-YvvLduXvI7Zb2geDu_4CvnZW0w priority: 102 providerName: Scholars Portal |
| Title | Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1α promoter methylation in healthy subjects |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29261667 https://www.proquest.com/docview/1979770054 https://www.proquest.com/docview/1979508133 https://pubmed.ncbi.nlm.nih.gov/PMC5737973 https://doaj.org/article/1d3b62e7e4c54e409512899bbf80d558 http://dx.doi.org/10.1371/journal.pone.0188208 |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELagXLggyl8DZTVIHEAi7dqO4-RIV91WSFQVotLeIjt2aMQ2G212QftYPAU3nomZJLvaRZV64eJDPJaTzIz9TTL-hrG3cex9mioZFomQGKCYIrS4E2CU4iPti5T4WSjb4iI-v4o-TdRkq9QX5YR19MDdizvmTtpYeO2jXEU-IkRAMYK1RTJ0SrXHfHHPWwdT3RqMXhzH_UE5qflxr5ejelb5oyFHVEnlJLc2opavn_hNp7PmNqz5b8rk1h40fswe9eARPnY3vc_u-eoJ2-_ds4F3PYf0-6fsN_o9pZt7B9OyLh2YH6acdpzcK0CgCgtUogdnVg3Mib4Vx_-kWrlgZ24FfSY7LOuF-e4_AB2mLOcN3CwbnBlucB3AdbNyZL5AeyPpF0zloKRsJAKwMKspI6z6Bn3OCKDE5dko5H9-Qd1mAfo5UAXrVZePh0OhO5a5gmZp6QNR84xdjU-_js7DvmZDmCsRL0I7zLXxqTIYeRlr0yLnRaKF0Lkcegw9rStSj6BNOh17lTuHGMUg7DHKp0MvjHzO9irU0gEDoQQKWJVzhKjGYFwY-dwlMWJYrmUaBUyuFZjlPaE51dWYZu1fOo2BTaeWjNSe9WoPWLgZVXeEHnfIn5BtbGSJjru9gEaa9Uaa3WWkATsgy1pP0GQ81Qi8CS8H7HBtbbd3v9l0o-PT3xxT-dmyk0F0zaUM2IvOODc3KVIMjONYB0zvmO3OU-z2VOV1Sy6utMS55cv_8div2ENBKIgLXIwP2d5ivvSvEcMt7IDd1xONbTLi1I7PBuzByenF5ZdB68jYfo6Sv6dpUUM |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKOcAFUf66UGCQQAKJtImdxJsDQlAoW1oqDq20t2DHTonYJmGzS5WXQuIpuPFMzORn6aIKTr2ux3FWM_7mm3g8w9jjMLQ2igLhpEMuMEBRqaPRE2CUYn1p04jqs1C2xUE4OvLfj4PxCvve34WhtMoeExugNkVC38i3vEgiVSGG8bL86lDXKDpd7VtotGaxZ-tTDNmqF7tvUL9PON95e7g9crquAk4S8HDmaDeRykaBwthAaR2liZcOJecyEa7F4EibNLJIK4SRoQ0SY9CLKnTMKrCRa7kS-NxL7DI6Xpd2lBwvAjzEjjDsrucJ6W111rBZFrnddD3kstTE8oz7a7oEUFXVSVGdx3D_TtQ84_l2rrNrHWWFV62NrbEVm99gax0oVPC0q1z97Cb7iWhDSe7WwCQrMwPqm8ombSXwGpAewwxNx4JRdQVTKhqL80-pQy_owtTQ5c_DvJypL_Y50BXObFrBybzCleEE0QfROje0aYA8MlkVqNxARjlQRJuhKCkPLT-GLlMFUOLju23H-_UDyib30E6B-mbXbRYgToX2MmgN1VzTZ6nqFju6EJ3eZqs5ammdAQ84Cugg8ZAYK4XRqG8TMwyROXtSRP6AiV6BcdKVUaduHpO4ORuUGE61aolJ7XGn9gFzFrPKtozIf-Rfk20sZKkIePNDMT2OO0yJPSN0yK20fhL41ieyTOGz1unQNUGAD1kny-oXqOI_e2jANnprO3_40WIY4YbOkFRui3krg5zeE2LA7rTGuXhJHmE4HoZywOSS2S79i-WRPPvclDQPpMC1xd1_v9ZDdmV0-GE_3t892LvHrnJiWB5HoN9gq7Pp3N5HfjjTD5pNCezTRaPAb1xIgg8 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKkRAXRPnrQoFBAgkk0t3Ycbw5IAQtS0tR1QOVekvt2CkR2yRsdqnyWFx5AW48EzNJdumiCk69ru04q5n55pt4PMPY0zB0Loqk8NIhFxig6NQz6AkwSnGBcmlE9Vko22I_3DkMPhzJoxX2Y34XhtIq55jYALUtEvpG3vcjhVSFGEY_7dIiDrZHr8uvHnWQopPWeTuNVkX2XH2G4Vv1ancbZf2M89G7T1s7XtdhwEskD6eeGSRKu0hqjBO0MVGa-OlQca4SMXAYKBmbRg4phrAqdDKxFj2qRietpYsGjmuBz73CriohfbIxdbQI9hBHwrC7qieU3-80Y7Mscrc58JHXUkPLc66w6RhAFVbHRXUR2_07afOcFxzdZDc6-gpvWn1bYysuv8XWOoCo4HlXxfrFbfYTkYcS3p2FcVZmFvQ3nY3bquA1IFWGKaqRA6vrCiZUQBbXn1G3XjCFraHLpYdZOdVf3Eug65zZpILTWYU7wykiESJ3bsmAgLwzaRjo3EJG-VBEoaEoKSctP4EuawVwxsH7Lc__9R3KJg_RTYB6aNdtRiAuhfZiaA3VzNAnquoOO7wUmd5lqzlKaZ0BlxwnGJn4SJK1xsg0cIkdhsiifSWioMfEXIBx0pVUp84e47g5J1QYWrViiUnscSf2HvMWq8q2pMh_5r8l3VjMpYLgzQ_F5CTu8CX2rTAhd8oFiQxcQMSZQmlj0uHASokPWSfNmm9QxX_sqcc25tp28fCTxTBCD50n6dwVs3YO8ntfiB671yrn4iV5hKF5GKoeU0tqu_Qvlkfy7HNT3lwqgXuL-_9-rcfsGtp__HF3f-8Bu86JbPkcMX-DrU4nM_cQqeLUPGpsEtjxZYPAb-gWhkU |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+lipid+availability+for+three+days+reduces+whole+body+glucose+uptake%2C+impairs+muscle+mitochondrial+function+and+initiates+opposing+effects+on+PGC-1%CE%B1+promoter+methylation+in+healthy+subjects&rft.jtitle=PloS+one&rft.au=Roy+Eldor&rft.au=Luke+Norton&rft.au=Marcel+Fourcaudot&rft.au=Cynthia+Galindo&rft.date=2017-12-20&rft.pub=Public+Library+of+Science+%28PLoS%29&rft.eissn=1932-6203&rft.volume=12&rft.issue=12&rft.spage=e0188208&rft_id=info:doi/10.1371%2Fjournal.pone.0188208&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_1d3b62e7e4c54e409512899bbf80d558 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |